Status:
ACTIVE_NOT_RECRUITING
Evaluating the Use of Patient Navigation to Promote Timely Diagnostic Evaluation During the COVID-19 Pandemic
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Association of University Radiologists (AUR) - GERRAF
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The primary objective of this project is to evaluate the role of patient navigation in promoting timely follow-up of abnormal breast imaging findings in patient populations that have been most severel...
Detailed Description
Patients who meet the study selection criteria will be randomized into two groups in a 1:1 ratio: the usual care group and the intervention group. Initially, patients will be invited to participate in...
Eligibility Criteria
Inclusion
- Patients who have an abnormal screening mammogram (i.e. given a Breast Imaging-Reporting and Data System \[BI-RADS\] assessment category of 0) at the investigators' institution during the study period and have not yet undergone diagnostic evaluation
Exclusion
- Any study participant who is unable to provide consent to participate in the study will be excluded.
Key Trial Info
Start Date :
July 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT05181722
Start Date
July 18 2022
End Date
December 1 2026
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Breast Imaging clinics
Baltimore, Maryland, United States, 21093